Fedor Istvan, Zold Eva, Barta Zsolt
Department of Clinical Immunology, Institute of Internal Medicine, Faculty of Medicine, University of Debrecen, Moricz Zs. krt. 22, H-4032 Debrecen, Hungary.
Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Kassai u. 26, H-4012 Debrecen, Hungary.
J Clin Med. 2021 Dec 20;10(24):5984. doi: 10.3390/jcm10245984.
Thus far, few attempted to characterize the temporal onset of extraintestinal manifestations (EIM) in inflammatory bowel diseases (IBD). We sought to determine the time of onset of these findings in a patient cohort with IBD.
We reviewed the electronic health records of 508 IBD patients (303 CD, 205 UC) and summarized general patient characteristics and the temporal relationship and order of presentation of extraintestinal manifestations.
CD patients were younger at diagnosis. CD patients with ileocolonic involvement (L3) were younger, and UC patients with pancolitis (E3) were slightly younger at diagnosis. A total of 127 out of 303 (41.91%) CD and 81 out of 205 (39.51%) UC patients had EIMs ( = 0.5898). Some patients presented with EIMs before the diagnosis of IBD (9.45% of Crohn's disease and 17.28% of ulcerative colitis patients with EIMs, respectively). Of these, seven cases (four in CD and three in UC) were visible by inspection of the patients (either dermatologic or ocular findings). The diagnosis of IBD and extraintestinal symptoms often occurred within a year (22.83% of CD and 16.04% of UC patients). Typically, the diagnosis of the first extraintestinal symptoms happened after the onset of bowel disease (+4.3 (±6.3) years, range: 10 years before to 30 years after in Crohn's disease and +3.8 (±10) years, range: 24 years before to 30 years after) in ulcerative colitis. UC patients with pancolitis (E3) usually had EIMs earlier in the disease course and displayed EIMs more frequently before IBD diagnosis. Furthermore, patients with pancolitis developed EIMs more frequently than other sub-groups.
Extraintestinal manifestations in inflammatory bowel diseases can present at any time, relative to the bowel symptoms. In cases, the presence of a characteristic EIM might be a harbinger of the development of IBD.
迄今为止,很少有人尝试描述炎症性肠病(IBD)肠外表现(EIM)的发病时间。我们试图确定IBD患者队列中这些表现的发病时间。
我们回顾了508例IBD患者(303例克罗恩病,205例溃疡性结肠炎)的电子健康记录,并总结了患者的一般特征以及肠外表现的时间关系和出现顺序。
克罗恩病患者诊断时年龄较小。回结肠受累(L3)的克罗恩病患者诊断时年龄较小,全结肠炎(E3)的溃疡性结肠炎患者诊断时年龄稍小。303例(41.91%)克罗恩病患者和205例(39.51%)溃疡性结肠炎患者中有127例出现了肠外表现(P = 0.5898)。一些患者在IBD诊断之前就出现了肠外表现(分别占克罗恩病和溃疡性结肠炎肠外表现患者的9.45%和17.28%)。其中,7例(4例克罗恩病,3例溃疡性结肠炎)通过检查患者即可发现(皮肤或眼部表现)。IBD和肠外症状的诊断通常在一年内发生(分别占克罗恩病和溃疡性结肠炎患者的22.83%和16.04%)。通常,首次肠外症状的诊断发生在肠道疾病发病之后(克罗恩病为+4.3(±6.3)年,范围:发病前10年至发病后30年;溃疡性结肠炎为+3.8(±10)年,范围:发病前24年至发病后30年)。全结肠炎(E3)的溃疡性结肠炎患者通常在病程中较早出现肠外表现,且在IBD诊断之前更频繁地出现肠外表现。此外,全结肠炎患者比其他亚组更频繁地出现肠外表现。
炎症性肠病的肠外表现相对于肠道症状可在任何时间出现。在某些情况下,特征性肠外表现的出现可能是IBD发生的先兆。